# Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia

> **NCT01550640** · NA · COMPLETED · sponsor: **Charles University, Czech Republic** · enrollment: 149 (actual)

## Conditions studied

- Pregnancy
- Cesarean Delivery
- General Anesthesia

## Interventions

- **DRUG:** Remifentanil

## Key facts

- **NCT ID:** NCT01550640
- **Lead sponsor:** Charles University, Czech Republic
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-03
- **Primary completion:** 2014-04
- **Final completion:** 2014-08
- **Target enrollment:** 149 (ACTUAL)
- **Last updated:** 2014-11-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01550640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01550640, "Pharmacogenetics of Remifentanil in Patients With Hypertension Undergoing Cesarean Delivery Under General Anesthesia". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01550640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*